MedCity News June 27, 2022
Michael Abrams

Consolidated healthcare systems – even cross market systems – don’t have to raise their prices to have anticompetitive effects. They can leverage their size by using the volume of their purchases to extract discounts and other concessions from payers, national suppliers, and from labor pools.

We are beginning the end game of healthcare consolidation. Over the past decade, we’ve seen a burst of activity in healthcare mergers. At this point, most of the smaller, attractive provider organizations have been acquired by the bigger players. The current landscape is dominated by larger healthcare delivery entities, and in their search for acquisitions they are coming up with other large players. Last year, we saw more billion dollar plus deals than in the...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Govt Agencies, Health System / Hospital, Mergers & Acquisitions / JV, Patient / Consumer, Provider, Regulations, Trends
Spinoffs, sales and tuck-ins top medtech deal priorities: Moody’s
Cerevel Parkinson’s data adds lustre to AbbVie acquisition
Ten Things to Know About Consolidation in Health Care Provider Markets
Pacifica Adds 15 Communities in $180.5M Deal, as RHF Shifts Senior Living Strategy
PurposeCare Bucks Historic Home-Based Care M&A Inactivity Trend In Q1

Share This Article